These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 24251365)

  • 1. Total synthesis and anti-hepatitis C virus activity of MA026.
    Shimura S; Ishima M; Nakajima S; Fujii T; Himeno N; Ikeda K; Izaguirre-Carbonell J; Murata H; Takeuchi T; Kamisuki S; Suzuki T; Kuramochi K; Watashi K; Kobayashi S; Sugawara F
    J Am Chem Soc; 2013 Dec; 135(50):18949-56. PubMed ID: 24251365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MA026, an anti-hepatitis C virus compound, opens tight junctions of the epithelial cell membrane.
    Kanda Y; Yamasaki Y; Shimura S; Kamisuki S; Sugawara F; Nagumo Y; Usui T
    J Antibiot (Tokyo); 2017 May; 70(5):691-694. PubMed ID: 28096546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific inhibition of hepatitis C virus entry into host hepatocytes by fungi-derived sulochrin and its derivatives.
    Nakajima S; Watashi K; Kamisuki S; Tsukuda S; Takemoto K; Matsuda M; Suzuki R; Aizaki H; Sugawara F; Wakita T
    Biochem Biophys Res Commun; 2013 Nov; 440(4):515-20. PubMed ID: 24099774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural Revision of Natural Cyclic Depsipeptide MA026 Established by Total Synthesis and Biosynthetic Gene Cluster Analysis.
    Uchiyama C; Fukuda A; Mukaiyama M; Nakazawa Y; Kuramochi Y; Muguruma K; Arimoto M; Ninomiya A; Kako K; Katsuyama Y; Konno S; Taguchi A; Takayama K; Taniguchi A; Nagumo Y; Usui T; Hayashi Y
    Angew Chem Int Ed Engl; 2021 Apr; 60(16):8792-8797. PubMed ID: 33533101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of 2'-fluoro and 2',4'-dimethyl pyrimidine C-nucleoside analogues as potential anti-HCV agents.
    Liu LJ; Hong JH
    Nucleosides Nucleotides Nucleic Acids; 2010 Mar; 29(3):216-27. PubMed ID: 20408052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of 1-boraadamantaneamine derivatives with selective astrocyte vs C6 glioma antiproliferative activity. A novel class of anti-hepatitis C agents with potential to bind CD81.
    Wagner CE; Mohler ML; Kang GS; Miller DD; Geisert EE; Chang YA; Fleischer EB; Shea KJ
    J Med Chem; 2003 Jul; 46(14):2823-33. PubMed ID: 12825926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and in vitro activity evaluation of 2',3'-C-dimethyl carbocyclic nucleoside analogues as potential anti-HCV agents.
    Ko OH; Hong JH
    Nucleosides Nucleotides Nucleic Acids; 2009 Aug; 28(8):761-71. PubMed ID: 20183615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A highly convergent and efficient synthesis of a macrocyclic hepatitis C virus protease inhibitor BI 201302.
    Wei X; Shu C; Haddad N; Zeng X; Patel ND; Tan Z; Liu J; Lee H; Shen S; Campbell S; Varsolona RJ; Busacca CA; Hossain A; Yee NK; Senanayake CH
    Org Lett; 2013 Mar; 15(5):1016-9. PubMed ID: 23406520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C virus entry into hepatocytes: molecular mechanisms and targets for antiviral therapies.
    Zeisel MB; Fofana I; Fafi-Kremer S; Baumert TF
    J Hepatol; 2011 Mar; 54(3):566-76. PubMed ID: 21146244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of 3'-C-hydroxymethyl-substituted pyrimidine and purine nucleosides as potential anti-hepatitis C virus (HCV) agents.
    Pei X; Choi WJ; Kim YM; Zhao LX; Jeong LS
    Arch Pharm Res; 2008 Jul; 31(7):843-9. PubMed ID: 18704325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potent inhibitors of the hepatitis C virus NS3 protease: use of a novel P2 cyclopentane-derived template.
    Johansson PO; Bäck M; Kvarnström I; Jansson K; Vrang L; Hamelink E; Hallberg A; Rosenquist A; Samuelsson B
    Bioorg Med Chem; 2006 Aug; 14(15):5136-51. PubMed ID: 16675222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel 1,2,4-triazole and imidazole derivatives of L-ascorbic and imino-ascorbic acid: synthesis, anti-HCV and antitumor activity evaluations.
    Wittine K; Stipković Babić M; Makuc D; Plavec J; Kraljević Pavelić S; Sedić M; Pavelić K; Leyssen P; Neyts J; Balzarini J; Mintas M
    Bioorg Med Chem; 2012 Jun; 20(11):3675-85. PubMed ID: 22555152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological activity of 5',9-anhydro-3-purine-isonucleosides as potential anti-hepatitis C virus agents.
    Chun BK; Wang P; Hassan A; Du J; Tharnish PM; Murakami E; Stuyver L; Otto MJ; Schinazi RF; Watanabe KA
    Nucleosides Nucleotides Nucleic Acids; 2007; 26(1):83-97. PubMed ID: 17162589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel hepatitis C virus replicon inhibitors: synthesis and structure-activity relationships of fused pyrimidine derivatives.
    Krueger AC; Madigan DL; Beno DW; Betebenner DA; Carrick R; Green BE; He W; Liu D; Maring CJ; McDaniel KF; Mo H; Molla A; Motter CE; Pilot-Matias TJ; Tufano MD; Kempf DJ
    Bioorg Med Chem Lett; 2012 Mar; 22(6):2212-5. PubMed ID: 22342631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First example of phosphoramidate approach applied to a 4'-substituted purine nucleoside (4'-azidoadenosine): conversion of an inactive nucleoside to a submicromolar compound versus hepatitis C virus.
    Perrone P; Daverio F; Valente R; Rajyaguru S; Martin JA; Lévêque V; Le Pogam S; Najera I; Klumpp K; Smith DB; McGuigan C
    J Med Chem; 2007 Nov; 50(22):5463-70. PubMed ID: 17914786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selection of peptides binding to HCV e2 and inhibiting viral infectivity.
    Hong HW; Lee SW; Myung H
    J Microbiol Biotechnol; 2010 Dec; 20(12):1769-71. PubMed ID: 21193836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, and biological activity of m-tyrosine-based 16- and 17-membered macrocyclic inhibitors of hepatitis C virus NS3 serine protease.
    Chen KX; Njoroge FG; Pichardo J; Prongay A; Butkiewicz N; Yao N; Madison V; Girijavallabhan V
    J Med Chem; 2005 Oct; 48(20):6229-35. PubMed ID: 16190750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. (-)-Epigallocatechin-3-gallate is a new inhibitor of hepatitis C virus entry.
    Calland N; Albecka A; Belouzard S; Wychowski C; Duverlie G; Descamps V; Hober D; Dubuisson J; Rouillé Y; Séron K
    Hepatology; 2012 Mar; 55(3):720-9. PubMed ID: 22105803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and anti-hepatitis C virus (HCV) activity of 3'-C-substituted-methyl pyrimidine and purine nucleosides.
    Choi WJ; Kim YM; Kim HO; Lee HW; Kim DE; Park KS; Chong Y; Jeong LS
    Bioorg Med Chem; 2010 Jul; 18(13):4812-20. PubMed ID: 20627592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of oleanane-type triterpenes as a new class of HCV entry inhibitors.
    Yu F; Wang Q; Zhang Z; Peng Y; Qiu Y; Shi Y; Zheng Y; Xiao S; Wang H; Huang X; Zhu L; Chen K; Zhao C; Zhang C; Yu M; Sun D; Zhang L; Zhou D
    J Med Chem; 2013 Jun; 56(11):4300-19. PubMed ID: 23662817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.